IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine binding
about
IRAK signalling in cancerRecent Progress in the Molecular Recognition and Therapeutic Importance of Interleukin-1 Receptor-Associated Kinase 4IRAK-4 inhibitors for inflammationInflammasome-associated nucleotide-binding domain, leucine-rich repeat proteins and inflammatory diseasesOutcome of a workshop on applications of protein models in biomedical researchDiscovery of AZD8931, an Equipotent, Reversible Inhibitor of Signaling by EGFR, HER2, and HER3 Receptors.Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4.Group B Streptococci Induce Proinflammatory Responses via a Protein Kinase D1-Dependent Pathway.Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy.Quantitative structure-activity relationship (QSAR) study of interleukin-1 receptor associated kinase 4 (IRAK-4) inhibitor activity by the genetic algorithm and multiple linear regression (GA-MLR) method.Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategySelective, C-3 Friedel-Crafts acylation to generate functionally diverse, acetylated Imidazo[1,2-]pyridine derivatives
P2860
Q26863735-0D1740E1-8E37-4534-9709-EE6BEB9791E4Q28078574-500A7FB8-F501-41AF-A306-EB332B3643A1Q28255508-077F1B60-B464-4177-970E-04C3BC868302Q28267534-77449607-5D13-40FC-AB06-D09594CFE1D1Q28751701-FD7B4793-BF74-4734-90A0-314B05451E99Q33635861-E310B8C5-D209-474B-ACD2-534AA38C64A0Q35745161-20FA6D68-3CC1-4445-B573-39AED7E832D1Q40230584-EB55E7AA-DD70-41A3-98BF-1E2861DE597CQ47753846-7A8C7346-EEEE-4DCE-940F-E505B37C6D2AQ51701309-9A5F199C-4809-45F0-9006-3A8228D9277EQ57116991-6FFDBC0E-707D-47B1-84EA-961A71CE4EF9Q57823477-48E3F90A-8DB6-47F8-AC5A-9A9B6A527005
P2860
IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine binding
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
IRAK-4 inhibitors. Part II: a ...... imidazo[1,2-a]pyridine binding
@ast
IRAK-4 inhibitors. Part II: a ...... imidazo[1,2-a]pyridine binding
@en
IRAK-4 inhibitors. Part II: a ...... imidazo[1,2-a]pyridine binding
@nl
type
label
IRAK-4 inhibitors. Part II: a ...... imidazo[1,2-a]pyridine binding
@ast
IRAK-4 inhibitors. Part II: a ...... imidazo[1,2-a]pyridine binding
@en
IRAK-4 inhibitors. Part II: a ...... imidazo[1,2-a]pyridine binding
@nl
prefLabel
IRAK-4 inhibitors. Part II: a ...... imidazo[1,2-a]pyridine binding
@ast
IRAK-4 inhibitors. Part II: a ...... imidazo[1,2-a]pyridine binding
@en
IRAK-4 inhibitors. Part II: a ...... imidazo[1,2-a]pyridine binding
@nl
P2093
P1476
IRAK-4 inhibitors. Part II: a ...... imidazo[1,2-a]pyridine binding
@en
P2093
Alicia Perez Higueruelo
Colin R Groom
David M Parry
George M Buckley
Joanne L Fraser
Kerry Jenkins
Lewis Gowers
Marianna D Richard
Oliver Rausch
Stephen R Mack
P304
P356
10.1016/J.BMCL.2008.04.039
P407
P577
2008-06-01T00:00:00Z